The Co-Investor Question: Why Capital Alone Does Not Build Biotech Winners

In biotech, the right co-investor determines success.

Peter M. Kovacs explains why alignment, execution discipline, and operational de-risking matter more than capital alone in building resilient, high-performing biotech and MedTech companies.